Australia markets close in 3 hours 21 minutes
  • ALL ORDS

    7,247.80
    -33.30 (-0.46%)
     
  • ASX 200

    7,018.80
    -26.10 (-0.37%)
     
  • AUD/USD

    0.7728
    -0.0002 (-0.02%)
     
  • OIL

    65.60
    -0.48 (-0.73%)
     
  • GOLD

    1,819.90
    -2.90 (-0.16%)
     
  • BTC-AUD

    65,319.09
    -8,914.05 (-12.01%)
     
  • CMC Crypto 200

    1,388.04
    -175.79 (-11.24%)
     
  • AUD/EUR

    0.6395
    -0.0004 (-0.06%)
     
  • AUD/NZD

    1.0777
    -0.0011 (-0.11%)
     
  • NZX 50

    12,463.90
    -100.31 (-0.80%)
     
  • NASDAQ

    13,001.63
    -349.63 (-2.62%)
     
  • FTSE

    7,004.63
    +56.64 (+0.82%)
     
  • Dow Jones

    33,587.66
    -681.50 (-1.99%)
     
  • DAX

    15,150.22
    +30.47 (+0.20%)
     
  • Hang Seng

    27,922.29
    -308.75 (-1.09%)
     
  • NIKKEI 225

    27,628.73
    -518.78 (-1.84%)
     

Insights on the Smart Inhalers Global Market to 2025 - Competitive Analysis and the Impact of COVID-19 - ResearchAndMarkets.com

·5-min read

The "Global Smart Inhalers Market (2020-2025) by Components, Product, Application, Distribution Channel, End-Use, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Smart Inhalers Market is estimated to be USD 118.35 Mn in 2020 and is expected to reach USD 257.38 Mn by 2025, growing at a CAGR of 16.81%.

Key factors such as growth in respiratory disorders such as asthma and Chronic Obstructive Pulmonary Diseases (COPD) and growing acceptance towards digital healthcare equipment have driven the demand for the smart inhaler market. Similarly, the demand for real-time monitoring devices in the healthcare sector has additionally supported the growth of the market further.

However, the high cost of smart inhalers and the evident presence and utilization of manual inhalers poses to be a restraining factor to the growth of the market.

Companies Mentioned

  • OPKO Health, Inc.

  • AstraZeneca plc

  • GlaxoSmithKline

  • Propeller Health (ResMed Inc)

  • Aptar Pharma

  • Novartis AG

  • Boehringer Ingelheim

  • Teva Pharmaceuticals

  • H&T Presspart Manufacturing Ltd.

  • Sensirion AG

  • Cohero Health, Inc (AptarGroup Inc)

  • Adherium Limited

  • Gecko Health Innovations, Inc (Teva Pharmaceuticals)

  • Agilent Technologies

  • 3M Medical

  • Inspiro Medical (OPKO Health Inc)

  • Findair Sp. z o. o.

  • Vectura Group

  • Zeolr Technologies Pvt Ltd.

  • ResMed, Inc.

Recent Developments
1. AptarGroup, Inc has partnered with Sonmol for developing connected drug delivery devices, digital therapies, and services platform for respiratory and other diseases - 21st April 2020
2. Teva Pharmaceuticals has got its 3rd Digi inhaler approved known as the ArmonAir Digihaler monotherapy maintenance treatment. It is considered the first-gen medicine-only dispenser. - 11th March 2020

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Smart Inhalers Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

  • The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.

  • The report also contains the competitive analysis using IGR Positioning Quadrants, the analyst's proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry

  • Important market dynamics and trends

  • Market segmentation

  • Historical, current, and projected size of the market based on value and volume

  • Market shares and strategies of key players

  • Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Rising prevalence of respiratory-related disorders
4.2.1.2 Growth in real-time monitoring devices
4.2.1.3 Rising acceptance towards digital healthcare equipment
4.2.2 Restraints
4.2.2.1 High price of the smart inhalers
4.2.2.2 Presence of manual inhalers
4.2.3 Opportunities
4.2.3.1 Technological Advancements
4.2.3.2 Growing collaborations between smart inhaler manufacturers and software companies
4.2.4 Challenges
4.2.4.1 Limited product availability in emerging markets
4.3 Trends

5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Smart Inhalers Market, By Component
6.1 Introduction
6.2 Solutions
6.3 Services

7 Global Smart Inhalers Market, By Product
7.1 Introduction
7.2 Inhalers
7.2.1 Dry Powder Inhaler
7.2.2 Metered-Dose Inhaler
7.3 Nebulizer

8 Global Smart Inhalers Market, By Application
8.1 Introduction
8.2 Asthma
8.3 COPD

9 Global Smart Inhalers Market, By Distribution channel
9.1 Introduction
9.2 Hospitals Pharmacies
9.3 Retail Pharmacies
9.4 Online channel

10 Global Smart Inhalers Market, By End Use
10.1 Introduction
10.2 Patients
10.3 R&D
10.4 Others

11 Global Smart Inhalers Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 South America
11.3.1 Brazil
11.3.2 Argentina
11.4 Europe
11.4.1 UK
11.4.2 France
11.4.3 Germany
11.4.4 Italy
11.4.5 Spain
11.4.6 Rest of Europe
11.5 Asia-Pacific
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Indonesia
11.5.5 Malaysia
11.5.6 South Korea
11.5.7 Australia
11.5.8 Russia
11.5.9 Rest of APAC
11.6 Rest of the World
11.6.1 Qatar
11.6.2 Saudi Arabia
11.6.3 South Africa
11.6.4 United Arab Emirates
11.6.5 Latin America

12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Mergers & Acquisitions
12.3.2 Agreement, Collaborations, & Partnerships
12.3.3 New Product Launches & Enhancements
12.3.4 Investments & Funding

13 Company Profiles

14 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/af3i4k

View source version on businesswire.com: https://www.businesswire.com/news/home/20210416005277/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900